Knocking down Cav1 calcium channels implicated in Th2 cell activation prevents experimental asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 12, 2010, Pages 1310-1317

  Cabral, Marilena Djata ^a,b,c,g   Paulet, Pierre Emmanuel ^a,b,c,g   Robert, Virginie ^a,b,c,g   Gomes, Bruno ^a,b,c   Renoud, Marie Laure ^a,b,c   Savignac, Magali ^a,b,c,e   Leclerc, Catherine ^b,d,e   Moreau, Marc ^b,d,e   Lair, David ^g   Langelot, Marie ^g   Magnan, Antoine ^g   Yssel, Hans ^a   Mariamé, Bernard ^a,b,c   Guéry, Jean Charles ^a,b,c,f   Pelletier, Lucette ^a,b,c,e,f  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c IFR150   (France)

^d CNRS   (France)

^e GDR 2688   (France)

^f TOULOUSE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ DE NANTES   (France)

Author keywords

Allergic asthma; Antisense oligonucleotides; Th2 cells; Voltage dependent calcium channels

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYTOKINE; DIHYDROPYRIDINE DERIVATIVE; OVALBUMIN; VOLTAGE DEPENDENT ANION CHANNEL 1; VOLTAGE GATED CALCIUM CHANNEL; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CAV1 PROTEIN, MOUSE; CAVEOLIN 1;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ASTHMA; BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CAVEOLIN 1; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; OVALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH2 CELLS; UP-REGULATION;

EID: 77954500547     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200907-1166OC     Document Type: Article

References (47)

1. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218-230.
2. Barnes PJ. Role of GATA-3 in allergic diseases. Curr Mol Med 2008;8:330-334.
3. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
4. Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007;7:690-702. (Pubitemid 47327393)
5. Sloan-Lancaster J, Steinberg TH, Allen PM. Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype. J Immunol 1997;159:1160-1168. (Pubitemid 127484091)
6. Fowell DJ, Shinkai K, Liao XC, Beebe AM, Coffman RL, Littman DR, Locksley RM. Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells. Immunity 1999;11:399-409.
7. Fanger CM, Neben AL, Cahalan MD. Differential Ca2+ influx, KCa channel activity, and Ca2+ clearance distinguish Th1 and Th2 lymphocytes. J Immunol 2000;164:1153-1160.
8. Weber KS, Miller MJ, Allen PM. Th17 cells exhibit a distinct calcium profile from Th1 and Th2 Cells and have Th1-like motility and NF-AT nuclear localization. J Immunol 2008;180:1442-1450.
9. Fowell DJ. Signals for the execution of Th2 effector function. Cytokine 2009;46:1-6.
10. Vig M, Kinet JP. Calcium signaling in immune cells. Nat Immunol 2009;10:21-27.
11. Gomes B, Savignac M, Moreau M, Leclerc C, Lory P, Guery JC, Pelletier L. Lymphocyte calcium signaling involves dihydropyridine-sensitive L-type calcium channels: facts and controversies. Crit Rev Immunol 2004;24:425-448.
12. Oh-hora M, Rao A. The calcium/NFAT pathway: role in development and function of regulatory T cells. Microbes Infect 2009;11:612-619.
13. Stokes L, Gordon J, Grafton G. Non-voltage-gated L-type Ca2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits. J Biol Chem 2004;279:19566-19573.
14. Kotturi MF, Jefferies WA. Molecular characterization of L-type calcium channel splice variants expressed in human T lymphocytes. Mol Immunol 2005;42:1461-1474.
15. Kotturi MF, Hunt SV, Jefferies WA. Roles of CRAC and Ca(V)-like channels in T cells: more than one gatekeeper? Trends Pharmacol Sci 2006;27:360-367.
16. Badou A, Jha MK, Matza D, Mehal WZ, Freichel M, Flockerzi V, Flavell RA. Critical role for the beta regulatory subunits of Cav channels in T lymphocyte function. Proc Natl Acad Sci USA 2006;103:15529-15534. (Pubitemid 44625626)
17. Matza D, Badou A, Kobayashi KS, Goldsmith-Pestana K, Masuda Y, Komuro A, McMahon-Pratt D, Marchesi VT, Flavell RA. A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity 2008;28:64-74.
18. Matza D, Badou A, Jha MK, Willinger T, Antov A, Sanjabi S, Kobayashi KS, Marchesi VT, Flavell RA. Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc Natl Acad Sci USA 2009;106:9785-9790.
19. Jha MK, Badou A, Meissner M, McRory JE, Freichel M, Flockerzi V, Flavell RA. Defective survival of naive CD8+ T lymphocytes in the absence of the beta3 regulatory subunit of voltage-gated calcium channels. Nat Immunol 2009;10:1275-1282.
20. Savignac M, Gomes B, Gallard A, Narbonnet S, Moreau M, Leclerc C, Paulet P, Mariame B, Druet P, Saoudi A, et al. Dihydropyridine receptors are selective markers of Th2 cells and can be targeted to prevent Th2-dependent immunopathological disorders. J Immunol 2004;172:5206-5212.
21. Gomes B, Cabral MD, Gallard A, Savignac M, Paulet P, Druet P, Mariame B, Moreau M, Leclerc C, Guery JC, et al. Calcium channel blocker prevents T helper type 2 cell-mediated airway inflammation. Am J Respir Crit Care Med 2007;175:1117-1124.
22. Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci 1998;19:108-115.
23. Djata Cabral M, Renoud M-L, Gomes B, Savignac M, Paulet P, Moreau M, Leclerc C, Guéry JC, Pelletier L. Targeting dihydropyridine receptors expressed by Th2 cells prevent experimental asthma. Abstract presented at European Calcium Society. 3-6th June 2009, Smolenice, Slovakia.
24. Faroudi M, Zaru R, Paulet P, Muller S, Valitutti S. Cutting edge: T lymphocyte activation by repeated immunological synapse formation and intermittent signaling. J Immunol 2003;171:1128-1132.
25. Finotto S, De Sanctis GT, Lehr HA, Herz U, Buerke M, Schipp M, Bartsch B, Atreya R, Schmitt E, Galle PR, et al. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med 2001;193:1247-1260.
26. Tiwari S, Zhang Y, Heller J, Abernethy DR, Soldatov NM. Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit. Proc Natl Acad Sci USA 2006;103:17024-17029.
27. 2+ channel function and drug action. Trends Pharmacol Sci 1995;16:43-49.
28. Cahalan MD, Wulff H, Chandy KG. Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol 2001;21:235-252. (Pubitemid 32652595)
29. Kubo M, Kincaid RL, Webb DR, Ransom JT. The Ca2+/calmodulin-activated, phosphoprotein phosphatase calcineurin is sufficient for positive transcriptional regulation of the mouse IL-4 gene. Int Immunol 1994;6:179-188.
30. Guo L, Urban JF, Zhu J, Paul WE. Elevating calcium in Th2 cells activates multiple pathways to induce IL-4 transcription and mRNA stabilization. J Immunol 2008;181:3984-3993.
31. Poggi A, Rubartelli A, Zocchi MR. Involvement of dihydropyridine- sensitive calcium channels in human dendritic cell function. Competition by HIV-1 Tat. J Biol Chem 1998;273:7205-7209. (Pubitemid 28152736)
32. Vukcevic M, Spagnoli GC, Iezzi G, Zorzato F, Treves S. Ryanodine receptor activation by Cav 1.2 is involved in dendritic cell major histocompatibility complex class II surface expression. J Biol Chem 2008;283:34913-34922.
33. McRory JE, Hamid J, Doering CJ, Garcia E, Parker R, Hamming K, Chen L, Hildebrand M, Beedle AM, Feldcamp L, et al. The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution. J Neurosci 2004;24:1707-1718.
34. Sadighi Akha AA, Willmott NJ, Brickley K, Dolphin AC, Galione A, Hunt SV. Anti-Ig-induced calcium influx in rat B lymphocytes mediated by cGMP through a dihydropyridine-sensitive channel. J Biol Chem 1996;271:7297-7300.
35. Grafton G, Stokes L, Toellner KM, Gordon J. A non-voltage-gated calcium channel with L-type characteristics activated by B cell receptor ligation. Biochem Pharmacol 2003;66:2001-2009.
36. Barry EL, Gesek FA, Yu AS, Lytton J, Friedman PA. Distinct calcium channel isoforms mediate parathyroid hormone and chlorothiazide-stimulated calcium entry in transporting epithelial cells. J Membr Biol 1998;161:55-64.
37. Liao P, Yu D, Li G, Yong TF, Soon JL, Chua YL, Soong TW. A smooth muscle Cav1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine. J Biol Chem 2007;282:35133-35142.
38. Balijepalli RC, Foell JD, Hall DD, Hell JW, Kamp TJ. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci USA 2006;103:7500-7505.
39. Shao Y, Czymmek KJ, Jones PA, Fomin VP, Akanbi K, Duncan RL, Farach-Carson MC. Dynamic interactions between L-type voltage sensitive calcium channel (VSCC) Cav1.2 ({alpha}1C) subunits and ahnak in osteoblastic cells. Am J Physiol Cell Physiol 2009;296:C1076-C1078.
40. Fomin VP, Kronbergs A, Gunst S, Tang D, Simirskii V, Hoffman M, Duncan RL. Role of protein kinase C alpha in regulation of [Ca2+](I) and force in human myometrium. Reprod Sci 2009;16:71-79.
41. Rosenthal R, Strauss O. Ca2+-channels in the RPE. Adv Exp Med Biol 2002;514:225-235.
42. Navedo MF, Amberg GC, Votaw VS, Santana LF. Constitutively active L-type Ca2+ channels. Proc Natl Acad Sci USA 2005;102:11112-11117.
43. Nieves-Cintron M, Amberg GC, Navedo MF, Molkentin JD, Santana LF. The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc Natl Acad Sci USA 2008;105:15623-15628.
44. Santana LF, Navedo MF. Molecular and biophysical mechanisms of Ca2+ sparklets in smooth muscle. J Mol Cell Cardiol 2009;47:436-444.
45. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008;8:193-204. (Pubitemid 351323293)
46. Eisenbarth SC, Zhadkevich A, Ranney P, Herrick CA, Bottomly K. IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88. J Immunol 2004;172:4527-4534. (Pubitemid 38375270)
47. Dittrich AM, Chen HC, Xu L, Ranney P, Connolly S, Yarovinsky TO, Bottomly HK. A new mechanism for inhalational priming: IL-4 bypasses innate immune signals. J Immunol 2008;181:7307-7315.